Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Infants will no longer receive hepatitis B vaccine at birth, CDC announces - 2Defense Minister Katz finally condemns Jewish extremist violence against Palestinians
- 3Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- 4Web designers for Independent ventures
- 5Instructions to Explore the Universe of Vehicle Leases
- Israeli strikes in Gaza kill 25 people, Hamas health authority says
- Grasping Various Kinds of Local misdemeanors
- Top notch Feasting: A Manual for Worldwide Acclaimed Eateries
- African nations push to recognize crimes of colonialism in Algeria
- CDC changes kids' vaccine schedule, removing universal recommendation for some shots
- Becoming amazing at Systems administration: Individual and Expert Tips
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Climbing Mount Everest: An Individual Victory
- Top notch Remote Earphones for Audiophiles
